drugset / Trial / NCT02827578

Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia

NCT02827578

Phase 3 Unknown 588 enrolled IlDong Pharmaceutical Co Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

Efficacy and Safety of Tamsulosin/Solifenacin Combination therapy in Patients with voiding symptoms and moderate to severe storage symptoms due to Benign Prostate Hyperplasia : a randomized, double blinded, parallel design, active controlled, multi-center, phase 3 clinical trial

Timeline

Start
2016-01
Primary completion
2017-08
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Solifenacin Small molecule
Background Tamsulosin Other / unclassified